• Study of Lower Dose Olaparib Combined with Cobicistat to Improve Treatment Tolerance in Cancer Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Alisertib with Hormone Therapy for Patients with HR+, HER2- Recurrent or Metastatic Breast Cancer

    Recruiting

    2 1 1 1
    Portugal Spain
  • Evaluation of drug combination therapy (olaparib, nilotinib, tremelimumab, and durvalumab) for patients with advanced or metastatic solid tumors

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on Early Oxybutynin Treatment for Boys with Posterior Urethral Valves

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Effect of Recombinant Human Interferon Gamma 1b for Patients with Post-Aggressive Immunosuppression in Intensive Care

    Recruiting

    3 1 1
    Investigated diseases:
    France
  • Study on Reducing Inflammation After Cataract Surgery Using Nepafenac and Dexamethasone for Patients Undergoing Surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study on Atezolizumab, Amivantamab, and Futibatinib for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain Sweden
  • Study of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis

    Recruiting

    4 1 1
    Investigated diseases:
    France
  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated diseases:
    Germany
  • Study on the Effects of Esketamine Hydrochloride and Propofol for Patients After Cardiac Arrest

    Recruiting

    3 1 1 1
    Investigated diseases:
    Denmark

powered by